Back to results
US 2015/0148423 A1Published application
Use of n-acetylcysteine amide in the treatment of disease and injury
AssigneeSentient Lifesciences, Inc.
InventorGlenn A. Goldstein
Life of this patent
Estimating the term…
Abstract
This disclosure describes methods of use for N-acetylcysteine amide for the treatment of various disorders
Claims11
A method of treating contrast induced nephropathy in a subject in need thereof comprising administering to the subject a composition comprising a therapeutically effective amount of N-acetylcysteine amide (NACA).
3-6. (canceled)
9-10. (canceled)
(canceled)
15-90. (canceled)
Dependencies are inferred from the claim text.